Latest news and thought leadership

All the latest from Deallus pharmaceutical and life science industry experts

China Pharma Market Access (CPMA)

September 13th, 2023|Categories: News, White Paper|Tags: |

Since the establishment of the China National Medical Insurance Bureau in 2018, the goal has been to strengthen public health and medical service levels, achieve maximum utilisation of the national medical insurance fund, and to enhance the strategic purchasing capability of medical insurance funds. Significant tools in achieving this are the National Reimbursement Drug List (NRDL) and drug Volume Based Procurement (VBP), which have opened a new chapter in China’s medical reform. Meanwhile, the new drug registration process is improved, simplified, and accelerated.

Deallus sponsoring and speaking at the Pharma CI EU Conference

March 6th, 2023|Categories: News|Tags: , |

We are excited to be sponsoring and speaking at the Pharma CI EU conference, held in Rome on 30-31 March 2023. Julie Munch Khan, COO, and Stephen Small, Senior Principal at Deallus will be joining other Competitive Intelligence experts across Pharma, Biotech and Medical Devices.


December 1st, 2022|Categories: News, White Paper|Tags: , |

Human immunodeficiency virus (HIV) is the virus that is responsible for Acquired Immune Deficiency Syndrome (AIDS). HIV continues to be a major global public health issue having claimed the lives of 36.3 million people so far, according to World Health Organization (WHO).

Pharma CI US 2020

Sponsors at Pharma CI US

Sept 29 – Oct 1, 2020

Learn more
PharmaCI Europe 2023

Sponsors at PharmaCI Europe

July 1-2, 2021
Zurich, Switzerland

Learn more

Register your email address to be alerted to our latest news

    Go to Top